These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 11682452)

  • 1. Nucleoside transporter subtype expression: effects on potency of adenosine kinase inhibitors.
    Sinclair CJ; Powell AE; Xiong W; LaRivière CG; Baldwin SA; Cass CE; Young JD; Parkinson FE
    Br J Pharmacol; 2001 Nov; 134(5):1037-44. PubMed ID: 11682452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine uptake and release in rat C6 glioma cells: nucleoside transport and purine metabolism under ATP-depleting conditions.
    Sinclair CJ; LaRivière CG; Young JD; Cass CE; Baldwin SA; Parkinson FE
    J Neurochem; 2000 Oct; 75(4):1528-38. PubMed ID: 10987833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equilibrative nucleoside transporters: mapping regions of interaction for the substrate analogue nitrobenzylthioinosine (NBMPR) using rat chimeric proteins.
    Sundaram M; Yao SY; Ng AM; Cass CE; Baldwin SA; Young JD
    Biochemistry; 2001 Jul; 40(27):8146-51. PubMed ID: 11434784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues.
    Yao SY; Ng AM; Muzyka WR; Griffiths M; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 1997 Nov; 272(45):28423-30. PubMed ID: 9353301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells.
    del Santo B; Valdés R; Mata J; Felipe A; Casado FJ; Pastor-Anglada M
    Hepatology; 1998 Dec; 28(6):1504-11. PubMed ID: 9828213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Cys140 in helix 4 as an exofacial cysteine residue within the substrate-translocation channel of rat equilibrative nitrobenzylthioinosine (NBMPR)-insensitive nucleoside transporter rENT2.
    Yao SY; Sundaram M; Chomey EG; Cass CE; Baldwin SA; Young JD
    Biochem J; 2001 Jan; 353(Pt 2):387-93. PubMed ID: 11139404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes.
    Gu JG; Nath A; Geiger JD
    J Neurochem; 1996 Sep; 67(3):972-7. PubMed ID: 8752102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
    Griffiths M; Yao SY; Abidi F; Phillips SE; Cass CE; Young JD; Baldwin SA
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):739-43. PubMed ID: 9396714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and glucose induced changes in expression level of nucleoside transporters and adenosine transport in rat T lymphocytes.
    Sakowicz M; Szutowicz A; Pawelczyk T
    Biochem Pharmacol; 2004 Oct; 68(7):1309-20. PubMed ID: 15345320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of nucleoside uptake by the basolateral side of the sheep choroid plexus epithelium perfused in situ.
    Markovic I; Segal M; Djuricic B; Redzic Z
    Exp Physiol; 2008 Mar; 93(3):325-33. PubMed ID: 18039975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.
    Aguayo C; Casado J; González M; Pearson JD; Martín RS; Casanello P; Pastor-Anglada M; Sobrevia L
    Placenta; 2005; 26(8-9):641-53. PubMed ID: 16085043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs.
    Sundaram M; Yao SY; Ng AM; Griffiths M; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 1998 Aug; 273(34):21519-25. PubMed ID: 9705281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex effects of sulfhydryl reagents on ligand interactions with nucleoside transporters: evidence for multiple populations of ENT1 transporters with differential sensitivities to N-ethylmaleimide.
    Vyas S; Ahmadi B; Hammond JR
    Arch Biochem Biophys; 2002 Jul; 403(1):92-102. PubMed ID: 12061806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine uptake-dependent C6 cell growth inhibition.
    Ohkubo S; Nagata K; Nakahata N
    Eur J Pharmacol; 2007 Dec; 577(1-3):35-43. PubMed ID: 17878054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2'-deoxyadenosine induces apoptosis in rat chromaffin cells.
    Wakade AR; Guo X; Palmer KC; Kulkarni JS; Przywara DA; Wakade TD
    J Neurochem; 1996 Dec; 67(6):2273-81. PubMed ID: 8931458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
    Cass CE; King KM; Montaño JT; Janowska-Wieczorek A
    Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
    Hammond JR
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells.
    Boleti H; Coe IR; Baldwin SA; Young JD; Cass CE
    Neuropharmacology; 1997 Sep; 36(9):1167-79. PubMed ID: 9364472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of ligand binding to the Ehrlich cell nucleoside transporter: pharmacological characterization of allosteric interactions with the [3H]nitrobenzylthioinosine binding site.
    Hammond JR
    Mol Pharmacol; 1991 Jun; 39(6):771-9. PubMed ID: 2051991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.